Drug class
Mucolytic and mucoregulator (S-carboxymethyl-L-cysteine)
Mechanism of action
Modifies the composition and amount of respiratory mucus glycoproteins, including the acid-to-neutral glycoprotein ratio, and reduces goblet-cell hyperplasia; this helps restore more normal mucus characteristics in hypersecretory respiratory disorders.
General use cases
- Management of respiratory disorders characterised by abnormal or excessive mucus, such as chronic bronchitis and other product-specified respiratory conditions
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
